Literature DB >> 7593633

Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity.

J R Panuska1, R Merolla, N A Rebert, S P Hoffmann, P Tsivitse, N M Cirino, R H Silverman, J A Rankin.   

Abstract

Respiratory syncytial virus (RSV) causes repeated infections thought to be due to an ineffective immune response. We examined the hypothesis that incomplete immunity may result, in part, from RSV-infected alveolar macrophage production of IL-10 which can interfere with the production of immunoregulatory cytokines. We also assessed whether RSV induced the expression of the 2',5' oligoadenylate (2-5A)-dependent RNase L, an endoribonuclease involved in the antiviral activities of interferons. Human alveolar macrophages were exposed to medium (uninfected control), RSV, LPS, and RSV + LPS then were assessed for expression of the cytokines TNF-alpha, IL-1 beta, IL-8, IL-10, as well as 2-5A-dependent RNase L. LPS up-regulated the expression of protein and mRNA for all cytokines. RSV stimulated the protein levels of TNF-alpha, did not alter IL-1 beta, and decreased IL-8. RSV markedly stimulated protein expression of IL-10 and 2-5A-dependent RNase L. RSV had minor effects on the steady state mRNA levels of TNF-alpha, IL-1 beta, and IL-8, yet potently induced IL-10. Cells costimulated with RSV + LPS demonstrated reduced protein and mRNA levels of TNF-alpha, IL-1 beta, IL-8 but synergistically increased IL-10 levels compared to RSV- or LPS-activated cells. Kinetic analysis indicated that RSV induced a delayed and sustained increase in IL-10 transcripts. Furthermore, RSV-infected alveolar macrophage supernatants suppressed IL-1 beta and IL-8 production by LPS-stimulated alveolar macrophages as did recombinant IL-10. Anti-IL-10 neutralized these effects. These studies indicate that RSV is capable of suppressing production of early immunoregulatory cytokines through induction of IL-10 perhaps mediated by 2-5A-dependent RNase L (or other endoribonucleases) accounting for the ineffective immune response to this virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593633      PMCID: PMC185897          DOI: 10.1172/JCI118302

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

Review 1.  Antigen presentation.

Authors:  E R Unanue; J C Cerottini
Journal:  FASEB J       Date:  1989-11       Impact factor: 5.191

Review 2.  The alveolar macrophage.

Authors:  A O Fels; Z A Cohn
Journal:  J Appl Physiol (1985)       Date:  1986-02

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.

Authors:  J Mestan; M Brockhaus; H Kirchner; H Jacobsen
Journal:  J Gen Virol       Date:  1988-12       Impact factor: 3.891

Review 5.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 6.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

7.  Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients.

Authors:  J R Panuska; M I Hertz; H Taraf; A Villani; N M Cirino
Journal:  Am Rev Respir Dis       Date:  1992-04

8.  Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

Authors:  M Connors; N A Giese; A B Kulkarni; C Y Firestone; H C Morse; B R Murphy
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.

Authors:  R C Welliver; D T Wong; M Sun; E Middleton; R S Vaughan; P L Ogra
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245

10.  Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.

Authors:  G H Wong; D V Goeddel
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

View more
  40 in total

1.  A defective type 1 response to rhinovirus in atopic asthma.

Authors:  N G Papadopoulos; L A Stanciu; A Papi; S T Holgate; S L Johnston
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

Review 2.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

3.  Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production.

Authors:  Vasile Laza-Stanca; Luminita A Stanciu; Simon D Message; Michael R Edwards; James E Gern; Sebastian L Johnston
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

Authors:  Nicholas W Lukacs; Martin L Moore; Brian D Rudd; Aaron A Berlin; Robert D Collins; Sandra J Olson; Samuel B Ho; R Stokes Peebles
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

5.  Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression.

Authors:  I S Lukashevich; R Maryankova; A S Vladyko; N Nashkevich; S Koleda; M Djavani; D Horejsh; N N Voitenok; M S Salvato
Journal:  J Med Virol       Date:  1999-12       Impact factor: 2.327

6.  Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells.

Authors:  Shirin Munir; Cyril Le Nouen; Cindy Luongo; Ursula J Buchholz; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkappaBbeta, and sequestration of protein phosphatase 2A by the viral phosphoprotein.

Authors:  V Bitko; S Barik
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae.

Authors:  Roongroje Thanawongnuwech; Brad Thacker; Patrick Halbur; Eileen L Thacker
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

9.  Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants.

Authors:  J H Aberle; S W Aberle; W Rebhandl; E Pracher; M Kundi; T Popow-Kraupp
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis.

Authors:  A Gagro; M Tominac; V Krsulović-Hresić; A Baće; M Matić; V Drazenović; G Mlinarić-Galinović; E Kosor; K Gotovac; I Bolanca; S Batinica; S Rabatić
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.